Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Dermatologic 1CNS 1

Conditions

Melanoma 7Neoplasm Metastasis 4Carcinoma, Renal Cell 4Carcinoma, Non-Small-Cell Lung 4Stomach Neoplasms 3Pancreatic Neoplasms 3Lymphoma, T-Cell, Cutaneous 3Lymphoma 3Colorectal Neoplasms 3Triple Negative Breast Neoplasms 2Sezary Syndrome 2Ovarian Neoplasms 2Mycosis Fungoides 2Lymphoma, Large-Cell, Anaplastic 2Lung Neoplasms 2Fallopian Tube Neoplasms 2Esophageal Neoplasms 2Colonic Neoplasms 2Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma 1Prostatic Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms, Basal Cell 1Neoplasms 1Multiple Myeloma 1Mesothelioma, Malignant 1

Interventions

trametinib 2dabrafenib 2binimetinib 2Trastuzumab 2Nivolumab 2Magnetic Resonance Spectroscopy 2Cisplatin 2ulixertinib 1trastuzumab biosimilar HLX02 1tipifarnib 1sapanisertib 1romidepsin 1ripretinib 1relatlimab 1pertuzumab 1pembrolizumab 1palbociclib 1osimertinib 1omipalisib 1larotrectinib 1ipatasertib 1glutathione pegylated liposomal doxorubicin 1erdafitinib 1entrectinib 1entinostat 1efineptakin alfa 1durvalumab 1defactinib 1copanlisib 1cobimetinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Glioma × Leucovorin × Dermatologic × Clear all
NCT05355701 2026-06-05

A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

Pfizer

Phase 1 Recruiting
267 enrolled
CNSDermatologicHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Glioma, Melanoma, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡